Single-pass whole-body (WB) 18F-FDG PET/CT imaging is routinely employed for the clinical assessment of malignant, infectious, and inflammatory diseases. Our aim in this study is the systematic clinical assessment of lesion detectability in multi-pass WB parametric imaging enabling direct imaging of the highly quantitative 18F-FDG influx rate constant Ki, as a complement to standard-of-care standardized uptake value (SUV) imaging for a range of oncologic studies
peer reviewedDespite advances in morphological imaging, some patients with lung cancer are found to ...
The aim of this study was to investigate the difference in the rates of FDG uptake between malignant...
In oncology, diagnostic imaging plays a major role in staging, therapy assessment and in the evaluat...
Background: Investigation of the clinical feasibility of dynamic whole-body (WB) [18F]FDG PET, inclu...
Current clinical whole-body PET imaging protocols reflect the trend followed in conventional nuclear...
The standardized uptake value (SUV) is the most commonly used parameter to quantify the intensity of...
Time-of-flight (TOF) PET has great potential in whole-body oncologic applications, and recent work h...
Hybrid dynamic imaging allows not only the estimation of whole-body (WB) macroparametric maps but al...
Whole-body (WB) dynamic positron emission tomography (PET) enables imaging of highly quantitative ph...
PurposeTo compare positron emission tomography (PET)/magnetic resonance (MR) imaging and PET/compute...
Because of its higher soft-tissue contrast, whole-body integrated PET/MR offers potential advantages...
This study aims to estimate the radiation effective dose resulting from whole body fluorine-18 flour...
PURPOSE:In this article, we discuss dynamic whole-body (DWB) positron emission tomography (PET) as a...
This study assessed the diagnostic accuracy of whole-body PET on a patient and lesion basis using 18...
Multimodality imaging, as represented by its greatest exponent, PET/CT, has a firm place in the eval...
peer reviewedDespite advances in morphological imaging, some patients with lung cancer are found to ...
The aim of this study was to investigate the difference in the rates of FDG uptake between malignant...
In oncology, diagnostic imaging plays a major role in staging, therapy assessment and in the evaluat...
Background: Investigation of the clinical feasibility of dynamic whole-body (WB) [18F]FDG PET, inclu...
Current clinical whole-body PET imaging protocols reflect the trend followed in conventional nuclear...
The standardized uptake value (SUV) is the most commonly used parameter to quantify the intensity of...
Time-of-flight (TOF) PET has great potential in whole-body oncologic applications, and recent work h...
Hybrid dynamic imaging allows not only the estimation of whole-body (WB) macroparametric maps but al...
Whole-body (WB) dynamic positron emission tomography (PET) enables imaging of highly quantitative ph...
PurposeTo compare positron emission tomography (PET)/magnetic resonance (MR) imaging and PET/compute...
Because of its higher soft-tissue contrast, whole-body integrated PET/MR offers potential advantages...
This study aims to estimate the radiation effective dose resulting from whole body fluorine-18 flour...
PURPOSE:In this article, we discuss dynamic whole-body (DWB) positron emission tomography (PET) as a...
This study assessed the diagnostic accuracy of whole-body PET on a patient and lesion basis using 18...
Multimodality imaging, as represented by its greatest exponent, PET/CT, has a firm place in the eval...
peer reviewedDespite advances in morphological imaging, some patients with lung cancer are found to ...
The aim of this study was to investigate the difference in the rates of FDG uptake between malignant...
In oncology, diagnostic imaging plays a major role in staging, therapy assessment and in the evaluat...